Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Opioid Induced Constipation Drugs Market

Opioid Induced Constipation Drugs Market Share

Report ID: GMI8483
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Opioid Induced Constipation Drugs Market Share

The opioid induced constipation drugs industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are among a key market strategy for opioid induced constipation drug manufacturers.

Opioid Induced Constipation Drugs Market Companies

Some of the eminent participants operating in the opioid induced constipation drugs industry include:

Atlantis Consumer Healthcare Inc.
Bausch Health Companies Inc.
Bayer AG
Cumberland Pharmaceuticals Inc.
Mallinckrodt Pharmaceuticals
Sanofi
Shionogi & Co., Ltd.
Valinor Pharma, LLC

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market valuation of the opioid induced constipation drugs was reached USD 2.1 billion in 2023 and is set to expand at 4.8% CAGR up to 2032, attributed to the increasing use of opioids coupled with the rising prevalence of gastrointestinal disorders.

Opioid induced constipation drugs market from the peripherally acting mu-opioid receptor agonists (PAMORAs) segment revenue crossed USD 706.3 million in 2023 owing to their growing demand to alleviate constipation associated with opioid use, addressing a critical need in patient care.

North America opioid induced constipation drugs industry size surpassed USD 858.2 million in 2023 and is poised to expand a notable CAGR from 2024 to 2032, attributed to the presence of an advanced healthcare infrastructure in the region.

Some of the leading opioid induced constipation drug firms are Atlantis Consumer Healthcare Inc., Bausch Health Companies Inc., Bayer AG, Cumberland Pharmaceuticals Inc., Mallinckrodt Pharmaceuticals, Sanofi, Shionogi & Co., Ltd., and Valinor Pharma, LLC